Skip to main content

Table 1 Number of patients included in GIPAP by country in 2010

From: Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program

Countries

Patients (N = 4,946)

%

Albania

84

1.7%

Armenia

167

3.4%

Azerbaijan

256

5.2%

Barbados

3

0.1%

Belarus

26

0.5%

Benin

19

0.4%

Bhutan

6

0.1%

Burkina Faso

20

0.4%

Cambodia

32

0.6%

Cameroon

53

1.1%

Côte d'Ivoire

52

1.1%

Ethiopia

279

5.6%

Fiji

15

0.3%

Gabon

9

0.2%

Georgia

252

5.1%

Ghana

69

1.4%

Haïti

8

0.2%

Kazakhstan

164

3.3%

Kenya

355

7.2%

Kyrgyzstan

105

2.1%

Madagascar

27

0.5%

Mali

48

1.0%

Mauritius

22

0.4%

Moldova

72

1.5%

Mongolia

7

0.1%

Mozambique

2

0.0%

Nepal

540

10.9%

Niger

5

0.1%

Nigeria

331

6.7%

Republic of Congo

24

0.5%

Rwanda

12

0.2%

Saint Lucia

6

0.1%

Senegal

84

1.7%

Seychelles

7

0.1%

Sierra Leone

2

0.0%

Sudan

971

19.6%

Surinam

12

0.2%

Tajikistan

1

0.0%

Tanzania

51

1.0%

Togo

38

0.8%

Uganda

90

1.8%

Uzbekistan

560

11.3%

Zambia

27

0.5%

Zimbabwe

33

0.7%